CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. Trademark License & Supply...Trademark License & Supply Agreement • February 20th, 2024 • Travere Therapeutics, Inc. • Pharmaceutical preparations • Texas
Contract Type FiledFebruary 20th, 2024 Company Industry JurisdictionThis Trademark License & Supply Agreement (“Agreement”) is made effective as of May 29, 2014 (the “Effective Date”) by and between Mission Pharmacal Company (“Mission”), a Texas corporation with an office at 10999 IH 10 West, Suite 1000, San Antonio, TX 78230, and Retrophin, Inc. (“Retrophin”) a Delaware corporation with an office at 777 Third Avenue, 22nd Floor, New York, NY 10017 (each side a “Party,” and collectively the “Parties”).
Trademark License & Supply AgreementTrademark License & Supply Agreement • June 4th, 2014 • Retrophin, Inc. • Pharmaceutical preparations • Texas
Contract Type FiledJune 4th, 2014 Company Industry JurisdictionThis Trademark License & Supply Agreement (“Agreement”) is made effective as of May 29, 2014 (the “Effective Date”) by and between Mission Pharmacal Company (“Mission”), a Texas corporation with an office at 10999 IH 10 West, Suite 1000, San Antonio, TX 78230, and Retrophin, Inc. (“Retrophin”) a Delaware corporation with an office at 777 Third Avenue, 22nd Floor, New York, NY 10017 (each side a “Party,” and collectively the “Parties”).